Table 3 2SC, FH, and additional immunohistochemistries performed in FH-deficient renal cell carcinomas
Cases | 2SC | FH | Vimentin | CD10 | P504S | CK7 | CA9 | TFE3 |
|---|---|---|---|---|---|---|---|---|
1 | − | − | ||||||
2 | + | − | + | − | + | − | ||
3 | + | − | − | + (Low) | − | − | ||
4 | + | − | − | − | + | − | − | |
5 | + | − | ||||||
6 | + | − | ||||||
7 | + | − | + | |||||
8 | + | − | − | + | + | |||
9 | + | + | + | − | − | |||
10 | − | − | + (Focal) | + (Low) | ||||
11 | + | − | ||||||
12 | + | − | ||||||
13 | + | − | − | + | − | |||
14 | + | − | ||||||
15 | + | − | + | − | − | − | ||
16 | + | − | ||||||
17 | + | + | ||||||
18 | + | − | − | + | − | + (Heterogenous) | ||
19 | + | − | ++ | + (Low) | − | + | − | |
20 | + | − | ||||||
21 | + | + | + | − | + (Low) | − | − | − |
22 | + | − | ||||||
23 | + | − | − | − | ||||
24 | + | − | − | − | + | − |
